• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰南部筛查时代乳腺导管原位癌患者的治疗和腋窝分期的时间趋势和医院间差异。

Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands.

机构信息

Eindhoven Cancer Registry, Comprehensive Cancer Centre South, PO Box 231, 5600 AE Eindhoven, The Netherlands.

Eindhoven Cancer Registry, Comprehensive Cancer Centre South, PO Box 231, 5600 AE Eindhoven, The Netherlands; Department of Epidemiology, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands.

出版信息

Breast. 2014 Feb;23(1):63-8. doi: 10.1016/j.breast.2013.11.001. Epub 2013 Dec 2.

DOI:10.1016/j.breast.2013.11.001
PMID:24291376
Abstract

BACKGROUND

To examine variation in time and place in axillary staging and treatment of patients with ductal carcinoma in situ (DCIS) of the breast.

METHODS

Trends in patients with DCIS recorded in the Eindhoven Cancer Registry diagnosed in 1991-2010 (n = 2449) were examined.

RESULTS

The use of breast conserving surgery (BCS) went from 17% to 67% in 1991-2010 and administration of radiotherapy after BCS increased to 89%. Axillary lymph node dissection decreased to almost 0%, while sentinel node biopsy was performed in 65% of patients in 2010. The proportion who underwent BCS varied between hospitals from 49% to 80%; the proportion without axillary staging ranged from 21% to 60%. Patients with screen-detected DCIS were more likely to receive BCS.

CONCLUSION

There was considerable variation in the use of BCS, radiotherapy, and axillary staging of DCIS over time and between hospitals. Patients with DCIS were more likely to be treated with BCS if their disease was detected by screening.

摘要

背景

本研究旨在考察乳腺导管原位癌(DCIS)患者腋窝分期和治疗的时间和地点差异。

方法

本研究回顾了 1991 年至 2010 年在埃因霍温癌症登记处诊断的 2449 例 DCIS 患者的趋势。

结果

1991 年至 2010 年间,保乳手术(BCS)的使用率从 17%上升至 67%,BCS 后放疗的使用率上升至 89%。腋窝淋巴结清扫术的使用率几乎降至 0%,而在 2010 年,65%的患者接受了前哨淋巴结活检。不同医院间 BCS 的使用率差异较大,从 49%至 80%不等;无腋窝分期的比例从 21%至 60%不等。通过筛查发现的 DCIS 患者更有可能接受 BCS。

结论

随着时间的推移和医院间的差异,BCS、放疗和腋窝分期在 DCIS 中的应用存在相当大的差异。如果疾病是通过筛查发现的,那么 DCIS 患者更有可能接受 BCS 治疗。

相似文献

1
Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands.荷兰南部筛查时代乳腺导管原位癌患者的治疗和腋窝分期的时间趋势和医院间差异。
Breast. 2014 Feb;23(1):63-8. doi: 10.1016/j.breast.2013.11.001. Epub 2013 Dec 2.
2
The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.医院和外科医生因素对导管原位癌腋窝淋巴结评估流行率的影响。
JAMA Oncol. 2015 Jun;1(3):323-32. doi: 10.1001/jamaoncol.2015.0389.
3
Analysis of Surgical Trends for Axillary Lymph Node Management in Patients with Ductal Carcinoma In Situ Using the NSQIP Database: Are We Following National Guidelines?利用 NSQIP 数据库分析导管原位癌患者腋窝淋巴结管理的手术趋势:我们是否遵循国家指南?
Ann Surg Oncol. 2020 Sep;27(9):3448-3455. doi: 10.1245/s10434-020-08374-0. Epub 2020 Mar 30.
4
Variation in management of early breast cancer in the Netherlands, 2003-2006.荷兰 2003-2006 年早期乳腺癌管理的变化。
Eur J Surg Oncol. 2010 Sep;36 Suppl 1:S36-43. doi: 10.1016/j.ejso.2010.06.021.
5
Optimal management of ductal carcinoma in situ of the breast.乳腺导管原位癌的优化管理
Surg Oncol. 2003 Dec;12(4):221-40. doi: 10.1016/S0960-7404(03)00031-8.
6
Quality indicators for ductal carcinoma in situ (DCIS) of the breast: development using a multidisciplinary delphi process and its use in monitoring population-based treatment.乳腺导管原位癌(DCIS)的质量指标:使用多学科 Delphi 流程开发及其在基于人群的治疗监测中的应用。
J Surg Oncol. 2013 Nov;108(6):348-51. doi: 10.1002/jso.23401. Epub 2013 Aug 22.
7
The management of ductal carcinoma in situ of the breast: a screened population-based analysis.乳腺导管原位癌的管理:一项基于筛查人群的分析。
Breast Cancer Res Treat. 2007 Mar;101(3):335-47. doi: 10.1007/s10549-006-9302-0. Epub 2006 Jul 13.
8
The impact of publication of Australian treatment recommendations for DCIS on clinical practice: A population-based, "before-after" study.澳大利亚导管原位癌治疗建议的发布对临床实践的影响:一项基于人群的“前后”研究。
Eur J Surg Oncol. 2010 Oct;36(10):949-56. doi: 10.1016/j.ejso.2010.07.008. Epub 2010 Aug 17.
9
Ductal carcinoma in situ: value of sentinel lymph node biopsy.导管原位癌:前哨淋巴结活检的价值
J Surg Oncol. 2006 Oct 1;94(5):426-30. doi: 10.1002/jso.20578.
10
Trends and clinicopathological predictors of axillary evaluation in ductal carcinoma in situ patients treated with breast-conserving therapy.保乳治疗的导管原位癌患者腋窝评估的趋势和临床病理预测因素。
Cancer Med. 2018 Jan;7(1):56-63. doi: 10.1002/cam4.1252. Epub 2017 Dec 22.

引用本文的文献

1
Evaluating the breast cancer quality of care indicators in Iran; multicenter study.评估伊朗乳腺癌护理质量指标;多中心研究。
BMC Cancer. 2025 May 23;25(1):925. doi: 10.1186/s12885-025-14260-3.
2
Surgeons' preferences for using sentinel lymph node biopsy in patients with ductal carcinoma in situ.外科医生对乳腺导管原位癌患者使用前哨淋巴结活检的偏好。
PLoS One. 2022 Jun 6;17(6):e0269551. doi: 10.1371/journal.pone.0269551. eCollection 2022.
3
Patterns of treatment and outcome of ductal carcinoma in situ in the Netherlands.荷兰导管原位癌的治疗模式和结局。
Breast Cancer Res Treat. 2021 May;187(1):245-254. doi: 10.1007/s10549-020-06055-w. Epub 2021 Jan 1.
4
Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study.根据乳腺癌亚型分析导管原位癌的范围:一项基于人群的队列研究。
Breast Cancer Res Treat. 2016 Jul;158(1):179-187. doi: 10.1007/s10549-016-3862-4. Epub 2016 Jun 18.
5
International variation in management of screen-detected ductal carcinoma in situ of the breast.乳腺筛查发现的导管原位癌管理的国际差异。
Eur J Cancer. 2014 Oct;50(15):2695-704. doi: 10.1016/j.ejca.2014.07.019. Epub 2014 Aug 19.